Long-term outcome of quetiapine use for psychosis among parkinsonian patients

To evaluate the long‐term efficacy and tolerability of quetiapine for psychosis among parkinsonian patients, a retrospective analysis of all parkinsonian patients taking quetiapine for psychosis in a single movement disorders center was carried out. Demographic data, including type and severity of p...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Movement disorders 2003-05, Vol.18 (5), p.510-514
Hauptverfasser:	Fernandez, Hubert H., Trieschmann, Martha E., Burke, Monica A., Jacques, Carol, Friedman, Joseph H.
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Antiparkinson Agents - therapeutic use Antipsychotic Agents - adverse effects Antipsychotic Agents - therapeutic use Biological and medical sciences Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases dementia Dibenzothiazepines - adverse effects Dibenzothiazepines - therapeutic use Drug Tolerance Drug-induced psychosis Dyskinesia, Drug-Induced - diagnosis Dyskinesia, Drug-Induced - epidemiology Dyskinesia, Drug-Induced - etiology Female Follow-Up Studies Humans Levodopa - therapeutic use long-term Male Medical sciences Neurology Neuropharmacology Outcome Assessment (Health Care) Parkinson Disease - drug therapy Parkinson Disease - psychology Parkinson's disease Pharmacology. Drug treatments Psycholeptics: tranquillizer, neuroleptic Psychology. Psychoanalysis. Psychiatry Psychopharmacology Psychotic Disorders - drug therapy Psychotic Disorders - epidemiology Psychotic Disorders - etiology quetiapine Quetiapine Fumarate Retrospective Studies Severity of Illness Index
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!